Your browser doesn't support javascript.
loading
Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.
Deckx, Sophie; Heggermont, Ward; Carai, Paolo; Rienks, Marieke; Dresselaers, Tom; Himmelreich, Uwe; van Leeuwen, Rick; Lommen, Wies; van der Velden, Jolanda; Gonzalez, Arantxa; Diez, Javier; Papageorgiou, Anna-Pia; Heymans, Stephane.
Afiliação
  • Deckx S; Center for Heart Failure Research, Cardiovascular Research Institute Maastricht, The Netherlands; Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium.
  • Heggermont W; Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium.
  • Carai P; Center for Heart Failure Research, Cardiovascular Research Institute Maastricht, The Netherlands; Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium.
  • Rienks M; Center for Heart Failure Research, Cardiovascular Research Institute Maastricht, The Netherlands.
  • Dresselaers T; Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Belgium.
  • Himmelreich U; Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Belgium.
  • van Leeuwen R; Center for Heart Failure Research, Cardiovascular Research Institute Maastricht, The Netherlands.
  • Lommen W; Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Belgium.
  • van der Velden J; Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands; ICIN-Netherlands Heart Institute, Utrecht, The Netherlands.
  • Gonzalez A; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Spain; CIBERCV, National Health Institute Carlos III, Ministry of Economy and Competitiveness, Spain.
  • Diez J; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Spain; CIBERCV, National Health Institute Carlos III, Ministry of Economy and Competitiveness, Spain.
  • Papageorgiou AP; Center for Heart Failure Research, Cardiovascular Research Institute Maastricht, The Netherlands; Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium. Electronic address: anna.papageorgiou@maastrichtuniversity.nl.
  • Heymans S; Center for Heart Failure Research, Cardiovascular Research Institute Maastricht, The Netherlands; Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium; ICIN-Netherlands Heart Institute, Utrecht, The Netherlands.
Matrix Biol ; 66: 110-124, 2018 03.
Article em En | MEDLINE | ID: mdl-28958774
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Angiotensina II / Peptídeos e Proteínas de Sinalização Intercelular / Hipertensão / Miocárdio Limite: Animals / Humans Idioma: En Revista: Matrix Biol Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Angiotensina II / Peptídeos e Proteínas de Sinalização Intercelular / Hipertensão / Miocárdio Limite: Animals / Humans Idioma: En Revista: Matrix Biol Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica